Showing 2,791 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Pharmaceutical industry

Injections against HIV could be manufactured locally and cheaply, says Aspen Pharmacare

Editor's pick
GroundUp
1 December 2022
Activism & civil society

Leadership Changes at PrEP4All, the HIV Prevention Advocacy Group

Editor's pick
POZ
30 November 2022
Injectable & long-acting PrEP

MSF: ViiV must make groundbreaking HIV prevention injection affordable and available

Editor's pick
MSF
29 November 2022
PrEP programmes & uptake

Emergency HIV Prevention for People Displaced in Ukraine

Editor's pick
The Global Fund
29 November 2022
PrEP programmes & uptake

The Barriers to PrEP Uptake Among People Who Inject Drugs

Editor's pick
Filter
22 November 2022
PrEP

Many People With Hepatitis C Could Benefit From HIV PrEP

Editor's pick
POZ
21 November 2022
Injectable & long-acting PrEP

Delays in global, affordable access to long-acting, injectable HIV medicines would cost lives, say AIDS campaigners

Editor's pick
UNAIDS
17 November 2022
PrEP programmes & uptake

Has HIV PrEP Uptake Increased Among High-Risk Persons?

Editor's pick
Contagion Live
16 November 2022
PrEP programmes & uptake

Zambian prison program for HIV PrEP enrolls 93% of eligible people

Editor's pick
Healio
12 November 2022
PrEP

In the US, lack of clinical training, HIV misconceptions are barriers to PrEP in the South

Editor's pick
Healio
8 November 2022
PrEP policies & guidelines

PrEP chaos: how central Europe is suffering from inconsistent guidelines, random access, and healthcare stigma

News
8 November 2022
PrEP programmes & uptake

South Africa to begin piloting injectable PrEP in early 2023

News
7 November 2022
PrEP policies & guidelines

UK: PrEP Could End HIV Transmissions But Tory Austerity Is Scuppering It

Editor's pick
Novara Media
4 November 2022
PrEP programmes & uptake

New report reveals extent of barriers to HIV prevention pill in England

Editor's pick
National AIDS Trust
3 November 2022
Global health targets

aidsmapLIVE: Can we end HIV transmission by 2030? Video

October 2022
HIV in the arts & media

Cheddar Gorgeous praised for “vital” HIV discussion on Drag Race UK

Editor's pick
Gay Times
31 October 2022
PrEP

PrEP options Video

October 2022
Injectable & long-acting PrEP

European Medicines Agency validates ViiV Healthcare’s marketing authorisation application for cabotegravir long-acting injectable for HIV Prevention

Editor's pick
ViiV press release
28 October 2022
Side effects

CD4 and white blood cell declines caused by islatravir are dose-related and reversible, but rule out using it for prevention

News
27 October 2022
PrEP programmes & uptake

Rapid scale-up of PrEP in Ukraine this year, despite the war

News
26 October 2022
PrEP

PrEP Awareness and Misconceptions Among Cisgender Women: Findings From IDWeek

Editor's pick
TheBodyPro
24 October 2022
Injectable & long-acting PrEP

Zimbabwe is the first county in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention

Editor's pick
World Health Organization
18 October 2022
PrEP programmes & uptake

Dedicated Pharmacists for HIV Pre-Exposure Prophylaxis Programs May Increase Uptake

Editor's pick
Infectious Disease Advisor
17 October 2022
PrEP programmes & uptake

New plan to increase demand for PrEP in Malawi

Editor's pick
Be In The Know
13 October 2022